{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:37:03Z","timestamp":1782275823250,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/dmd.124.001820","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T18:15:13Z","timestamp":1730225713000},"page":"100006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Heterotropic allosteric modulation of CYP3A4 in\u00a0vitro by progesterone: Evidence for improvement in prediction of time-dependent inhibition for macrolides"],"prefix":"10.1016","volume":"53","author":[{"given":"Luc R.A.","family":"Roug\u00e9e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja V.","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent L.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.124.001820_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/rvsc.1998.0244","article-title":"Macrolide antibiotics, drug interactions and microsomal enzymes: implications for veterinary medicine","volume":"66","author":"Anad\u00f3n","year":"1999","journal-title":"Res Vet Sci"},{"key":"10.1124\/dmd.124.001820_bib2","doi-asserted-by":"crossref","first-page":"14143","DOI":"10.1021\/bi051689t","article-title":"Cooperative binding of midazolam with testosterone and alpha-naphthoflavone within the CYP3A4 active site: a NMR T1 paramagnetic relaxation study","volume":"44","author":"Cameron","year":"2005","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.124.001820_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1051\/vetres:2003011","article-title":"In\u00a0vitro formation of metabolic-intermediate cytochrome P450 complexes in rabbit liver microsomes by tiamulin and various macrolides","volume":"34","author":"Carletti","year":"2003","journal-title":"Vet Res"},{"key":"10.1124\/dmd.124.001820_bib4","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1074\/jbc.M609589200","article-title":"Cooperativity in cytochrome P450 3A4: linkages in substrate binding, spin state, uncoupling, and product formation","volume":"282","author":"Denisov","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1124\/dmd.124.001820_bib5","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/acs.biochem.5b00079","article-title":"Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer","volume":"54","author":"Denisov","year":"2015","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.124.001820_bib6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1021\/acs.biochem.1c00161","article-title":"Midazolam as a probe for drug-drug interactions mediated by cyp3a4: homotropic allosteric mechanism of site-specific hydroxylation","volume":"60","author":"Denisov","year":"2021","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.124.001820_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3390\/biom12060853","article-title":"Midazolam as a probe for heterotropic drug-drug interactions mediated by CYP3A4","volume":"12","author":"Denisov","year":"2022","journal-title":"Biomolecules"},{"key":"10.1124\/dmd.124.001820_bib8","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1021\/acs.biochem.8b01268","article-title":"Allosteric interactions in human cytochrome P450 CYP3A4: the role of phenylalanine 213","volume":"58","author":"Denisov","year":"2019","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.124.001820_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jinorgbio.2015.12.019","article-title":"The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4","volume":"158","author":"Denisov","year":"2016","journal-title":"J\u00a0Inorg Biochem"},{"key":"10.1124\/dmd.124.001820_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cca.2017.05.002","article-title":"Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS\/MS: impact of gender, age, oral contraceptives, body mass index and blood pressure status","volume":"470","author":"Eisenhofer","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1124\/dmd.124.001820_bib11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0603236103","article-title":"Structural basis for ligand promiscuity in cytochrome P450 3A4","volume":"103","author":"Ekroos","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.124.001820_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1515\/cclm.2002.202","volume":"40","author":"Elmlinger","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1124\/dmd.124.001820_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/dmd.121.000356","volume":"49","author":"Eng","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001820_bib14","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1038\/s41598-019-42051-x","article-title":"Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations","volume":"9","author":"Filppula","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.124.001820_bib15","doi-asserted-by":"crossref","first-page":"13018","DOI":"10.1021\/jp810386z","article-title":"Theoretical characterization of substrate access\/exit channels in the human cytochrome P450 3A4 enzyme: involvement of phenylalanine residues in the gating mechanism","volume":"113","author":"Fishelovitch","year":"2009","journal-title":"J\u00a0Phys Chem B"},{"key":"10.1124\/dmd.124.001820_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/FPC.0000000000000270","article-title":"PharmGKB summary: macrolide antibiotic pathway, pharmacokinetics\/pharmacodynamics","volume":"27","author":"Fohner","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.124.001820_bib17","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1021\/acs.jcim.2c01264","article-title":"Molecular insights into the heterotropic allosteric mechanism in cytochrome P450 3A4-mediated midazolam metabolism","volume":"62","author":"Fu","year":"2022","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1124\/dmd.124.001820_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0009-9236(98)90146-1","article-title":"The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin","volume":"64","author":"Gorski","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001820_bib57","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1124\/dmd.109.026716","article-title":"The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America","volume":"37","author":"Grimm","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001820_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.clpt.6100222","article-title":"Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in\u00a0vivo","volume":"83","author":"Gurley","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001820_bib20","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1073\/pnas.95.12.6636","article-title":"Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics","volume":"95","author":"Harlow","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.124.001820_bib21","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1124\/dmd.114.058297","article-title":"A\u00a0numerical method for analysis of in\u00a0vitro time-dependent inhibition data. Part 2. Application to experimental data","volume":"42","author":"Korzekwa","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001820_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2020.12.001","article-title":"Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects","volume":"36","author":"Lee","year":"2021","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.124.001820_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1124\/dmd.124.001820_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-62703-758-7_5","article-title":"Irreversible enzyme inhibition kinetics and drug-drug interactions","volume":"1113","author":"Mohutsky","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.124.001820_bib24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/dmd.114.058289","article-title":"A\u00a0numerical method for analysis of in\u00a0vitro time-dependent inhibition data. Part 1. Theoretical considerations","volume":"42","author":"Nagar","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001820_bib25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/dmd.30.5.534","article-title":"Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes","volume":"30","author":"Nakamura","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001820_bib26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1124\/dmd.31.4.432","article-title":"CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids","volume":"31","author":"Nakamura","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001820_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/dmd.106.012633","article-title":"Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions","volume":"35","author":"Obach","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001820_bib29","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/jpet.105.093229","article-title":"The utility of in\u00a0vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions","volume":"316","author":"Obach","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001820_bib30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/0091270007302562","article-title":"Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans","volume":"47","author":"Okudaira","year":"2007","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1124\/dmd.124.001820_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/clpt.1993.25","article-title":"A\u00a0potentially hazardous interaction between erythromycin and midazolam","volume":"53","author":"Olkkola","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001820_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/00498258209038944","article-title":"Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents","volume":"12","author":"Pershing","year":"1982","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.124.001820_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00228-005-0091-x","article-title":"Quantitative prediction of macrolide drug-drug interaction potential from in\u00a0vitro studies using testosterone as the human cytochrome P4503A substrate","volume":"62","author":"Polasek","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001820_bib34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1021\/acs.bioconjchem.6b00604","article-title":"Allosteric activation of cytochrome P450 3A4 via progesterone bioconjugation","volume":"28","author":"Polic","year":"2017","journal-title":"Bioconjug Chem"},{"key":"10.1124\/dmd.124.001820_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/cpt.525","article-title":"Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A","volume":"101","author":"Prueksaritanont","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001820_bib36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2125.2007.02970.x","article-title":"Interaction between midazolam and clarithromycin in the elderly","volume":"65","author":"Quinney","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001820_bib37","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1021\/bi200924t","article-title":"The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4","volume":"50","author":"Roberts","year":"2011","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.124.001820_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ddtec.2004.10.002","article-title":"'In silico' simulations to assess the 'in\u00a0vivo' consequences of 'in\u00a0vitro' metabolic drug-drug interactions","volume":"1","author":"Rostami-Hodjegan","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1124\/dmd.124.001820_bib39","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1124\/dmd.123.001382","article-title":"Impact of heterotropic allosteric modulation on the time-dependent inhibition of cytochrome P450 3A4","volume":"51","author":"Roug\u00e9e","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001820_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105439","article-title":"Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review","volume":"194","author":"Schiffer","year":"2019","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1124\/dmd.124.001820_bib56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0076-6879(95)49038-8","article-title":"Mechanism-based enzyme inactivators","volume":"249","author":"Silverman","year":"1995","journal-title":"Methods Enzymol"},{"issue":"Suppl 161","key":"10.1124\/dmd.124.001820_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/aogs.12771","article-title":"Physiology, production and action of progesterone","volume":"94","author":"Taraborrelli","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1124\/dmd.124.001820_bib42","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/jcc.23008","article-title":"Metabolic-intermediate complex formation with cytochrome P450: theoretical studies in elucidating the reaction pathway for the generation of reactive nitroso intermediate","volume":"33","author":"Taxak","year":"2012","journal-title":"J\u00a0Comput Chem"},{"key":"10.1124\/dmd.124.001820_bib43","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1124\/dmd.121.000497","article-title":"Static and dynamic projections of drug-drug interactions caused by cytochrome P450 3A time-dependent inhibitors measured in human liver microsomes and hepatocytes","volume":"49","author":"Tseng","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001820_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/clpt.2013.187","article-title":"Evaluation of various static in vitro\u2013in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drug","volume":"95","author":"Vieira","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001820_bib45","first-page":"105","article-title":"Macrolide antibacterials. Drug interactions of clinical significance","volume":"13","author":"von Rosensteil","year":"1995","journal-title":"Drug Saf"},{"key":"10.1124\/dmd.124.001820_bib46","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1021\/acs.jcim.3c01837","article-title":"Probe substrate dependencies in CYP3A4 allosteric inhibition: a novel molecular mechanism involving F-F' loop perturbations","volume":"64","author":"Wei","year":"2024","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1124\/dmd.124.001820_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.2000.00261.x","article-title":"Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin","volume":"50","author":"Westphal","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001820_bib48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1126\/science.1099736","article-title":"Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone","volume":"305","author":"Williams","year":"2004","journal-title":"Science"},{"key":"10.1124\/dmd.124.001820_bib49","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1021\/acs.molpharmaceut.8b00129","article-title":"Improved predictions of drug-drug interactions mediated by time-dependent inhibition of CYP3A","volume":"15","author":"Yadav","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.124.001820_bib50","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/dmd.119.089599","article-title":"Critical impact of drug-drug interactions via intestinal CYP3A in the risk assessment of weak perpetrators using physiologically based pharmacokinetic models","volume":"48","author":"Yamada","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001820_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/abbi.1997.0302","article-title":"Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes","volume":"346","author":"Yamazaki","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.124.001820_bib52","first-page":"577","article-title":"Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin","volume":"35","author":"Yeates","year":"1997","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001820_bib53","first-page":"213","article-title":"Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam","volume":"46","author":"Zimmermann","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/dmd.124.001820_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/rvsc.1998.0239","article-title":"In\u00a0vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle","volume":"66","author":"Zweers-Zeilmaker","year":"1999","journal-title":"Res Vet Sci"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624148465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624148465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.124.001820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:36:12Z","timestamp":1761194172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624148465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0090955624148465"],"URL":"https:\/\/doi.org\/10.1124\/dmd.124.001820","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterotropic allosteric modulation of CYP3A4 in\u00a0vitro by progesterone: Evidence for improvement in prediction of time-dependent inhibition for macrolides","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.124.001820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100006"}}